Nalu Medical
- Company typePrivate
- Founded2019
- HeadquartersCarlsbad, United States
- Headcount101–250
- GTM typeB2B
- OfferingHardware or Manufacturing
Nalu Medical firmographics
Firmographics- Name
- Nalu Medical
- Legal name
- Nalu Medical, Inc.
- Website
- https://nalumed.com
- Company type
- Private
- Founded year
- 2019
- Operating status
- Acquired
- Headcount range
- 101–250 employees
- Ownership category
- akta.pro rank
Nalu Medical industry classification
Industry- Product category
- Implantable Neurostimulation Devices
- NAICS
- Surgical Appliance and Supplies Manufacturing (339113)
- SIC
- Electromedical & Electrotherapeutic Apparatus (3845)
- akta.pro primary industry
- Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS) (HLAHAEAK)
- akta.pro secondary industry
- Pain Medicine (Interventional/Neuropathic Pain) (HLAKAIAM)
Keywords
Where Nalu Medical is headquartered
LocationHeadquarters
- HQ city
- Carlsbad
- HQ country
- United States
- HQ region
- North America
Offices1 record
Markets served
Nalu Medical business model
Business model- GTM type
- B2B
- Offering type
- Hardware or Manufacturing
- Cost components
- Personnel, Supply Chain, Technology or R&D, Marketing or Sales, Operations, Infrastructure
Revenue model
- Neurostimulation System Sales: Sale of the Nalu Neurostimulation System including micro-IPG implants, Therapy Discs, leads, and accessories to healthcare providers. Revenue generated from commercial operations in the U.S. market.
Go-to-market motion1 record
Distribution channels1 record
Marketing channels6 records
Nalu Medical product offering
Product offeringCore offering
Nalu Medical develops and commercializes the Nalu Neurostimulation System, a battery-free, miniaturized neurostimulation platform for treating chronic intractable neuropathic pain of peripheral nerve origin and intractable trunk/limb pain. The system includes an implanted micro-Implantable Pulse Generator (micro-IPG), an externally worn Therapy Disc that powers the implant wirelessly, and a smartphone-based remote control app, and is FDA 510(k)-cleared for both Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) indications. Nalu also provides the cloud-based Patient Care Portal for patient engagement across the trial-to-post-implant continuum.
Product overview
Nalu Medical offers the Nalu Neurostimulation System, a unified multi-component platform for treating chronic neuropathic pain through both Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS). The system centers on the proprietary nPower microchip powering the battery-free micro-IPG (mIPG), the smallest commercially available implantable pulse generator at 27x smaller than competitors. The mIPG is complemented by the externally worn Therapy Disc (with TD2 as its latest generation offering 39% size reduction), controlled via smartphone app. The Dual 4 mIPG variant extends PNS capabilities with dual-lead support, while the Patient Care Portal provides cloud-based patient monitoring. All components are software-upgradeable without surgery.
Differentiator
Problem solved
Functional benefit
Products and services
- Nalu Neurostimulation System A multi-component, non-integrated neurostimulation system for treating chronic intractable neuropathic pain, FDA 510(k)-cleared for both Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS). The system comprises a battery-free implanted micro-Implantable Pulse Generator (micro-IPG), a separate electrode array, and an externally worn Therapy Disc that powers the implant wirelessly, with smartphone-based patient control. Designed for interventional pain specialists and pain management physicians treating patients who have failed conventional medical management.
- Therapy Disc (TD2) An externally worn device housing the battery and control circuitry that wirelessly powers the implanted micro-IPG, controlled by the patient via a smartphone app. The next-generation TD2 offers a 39% smaller volume than the prior Therapy Disc and incorporates a 3-axis MEMS accelerometer for activity monitoring, providing physicians and patients objective functional improvement data.
- Nalu Patient Care Portal A cloud-based software platform that engages patients with their multidisciplinary care teams from the trial period through post-implantation, enabling progress tracking and personalized pain management treatment plans. Used by interventional pain practices such as Premier Pain Centers to support patient tracking and recovery monitoring.
- Dual 4 mIPG A variant of the Nalu micro-Implantable Pulse Generator with dual connectors designed to accommodate two 4-contact stimulation leads for peripheral nerve stimulation applications. Provides increased treatment flexibility for addressing multiple nerve targets, utilized by pain physicians such as Dr. Amitabh Gulati for PNS applications.
Quantifiable outcome
- 85-87% responder rate (≥50% pain reduction) at 24 months
- +4 more outcomes
Companies that use Nalu Medical
Customer profileNamed customers6 records
Segments3 records
Ideal customer profiles1 record
Nalu Medical technology and API
TechnologyTechnology focussed Yes
API detail
- Has API
- No
- API docs
- API detail
Core technology
AI maturity
App detail
Feature8 records
Nalu Medical partnerships and signals
Strategic signalPartnerships
Two partnerships are on record, tiered core and minor.
- Boston ScientificcoreBoston Scientific announced definitive agreement to acquire Nalu Medical for approximately $533 million in upfront cash. Boston Scientific had been a strategic investor in Nalu since 2017. Transaction completed in late January 2026. Nalu's neurostimulation technology complements Boston Scientific's existing neuromodulation therapies including spinal cord stimulation, basivertebral nerve ablation, and radiofrequency ablation.
- Nevro CorporationminorNalu and Nevro reached settlement in patent infringement lawsuit brought by Nevro in February 2020. Settlement allows Nalu to maintain its current menu of therapy options.
Scale indicators8 records
Recent moves6 records
Expansion highlights6 records
Nalu Medical competitors and assessment
Company assessmentDirect peers
- Nevro Corp: Nevro is a direct competitor in the SCS market with its HF10 high-frequency therapy, and previously filed patent infringement litigation against Nalu (settled 2021), underscoring direct overlap in product category and clinical positioning.
- Saluda Medical: Saluda Medical developed the Evoke closed-loop SCS system with objective measurement of neural responses, directly competing in the chronic pain SCS market with differentiated waveform technology.
- Curonix (formerly Stimwave): Curonix is a direct PNS competitor with miniaturized, wirelessly powered peripheral nerve stimulators, sharing Nalu's core architectural approach of battery-free miniaturized implants and external wearable power sources.
Broad incumbents
- Medtronic: Medtronic is a dominant incumbent in spinal cord stimulation with its Intellis and Vanta platforms, offering overlapping chronic pain neuromodulation therapies to interventional pain physicians and competing with Nalu for the same clinical indications.
- Abbott: Abbott (which acquired St. Jude Medical's neuromodulation business) offers the Proclaim XR SCS system and Infinity DBS, directly competing in the chronic pain and neuromodulation space served by Nalu.
- Boston Scientific: Boston Scientific, now Nalu's parent company, is a broad neuromodulation incumbent with WaveWriter Alpha SCS, Precision Spectra, and other neurostimulation offerings — directly overlapping Nalu's product category within a much larger portfolio.
- Biotronik: Biotronik offers ProMRI-compatible spinal cord stimulators and other neurostimulation devices, competing in the chronic pain market with a portfolio extending across cardiovascular and neuromodulation verticals.
Emerging players
- SPR Therapeutics: SPR Therapeutics focuses on peripheral nerve stimulation with temporary 60-day SPRINT systems, addressing the same chronic peripheral nerve pain indications as Nalu's permanent PNS platform with a different care delivery model.
- Axonics: Axonics develops sacral and tibial neuromodulation systems for incontinence and chronic pain, with miniaturized rechargeable IPG technology. Founded by Nalu's Chairman Raymond Cohen; sold to Boston Scientific for $3.7B in 2024 — adjacent neuromodulation category with shared investor lineage.
Market position
Strengths1 record
Weaknesses5 records
Competitive moat6 records
Key risks6 records
Key highlights7 records
Customer concentration
Nalu Medical social profiles
Digital presenceNalu Medical compliance and trust
Trust signalCompliance3 records
Nalu Medical financial estimates
Financial estimateRevenue estimate
Valuation estimate
Nalu Medical leadership team
Management profileNumber of profiles
Profiles9 records
Nalu Medical funding detail
Funding detailFunding overview
Funding rounds5 records
Investors13 records
Funding detail is available on the Subscription and Enterprise plan.Contact sales →
Nalu Medical M&A and investment
M&A and investmentM&A
Investments
M&A and investment is available on the Subscription and Enterprise plan.Contact sales →
Frequently asked questions about Nalu Medical
What does Nalu Medical do?
Nalu Medical develops and commercializes the Nalu Neurostimulation System, a battery-free, miniaturized neurostimulation platform for treating chronic intractable neuropathic pain of peripheral nerve origin and intractable trunk/limb pain. The system includes an implanted micro-Implantable Pulse Generator (micro-IPG), an externally worn Therapy Disc that powers the implant wirelessly, and a smartphone-based remote control app, and is FDA 510(k)-cleared for both Spinal Cord Stimulation (SCS) and Peripheral Nerve Stimulation (PNS) indications. Nalu also provides the cloud-based Patient Care Portal for patient engagement across the trial-to-post-implant continuum.
Is Nalu Medical a public or private company?
Nalu Medical is a private company. It is classified as corporate owned and is currently acquired.
When was Nalu Medical founded?
Nalu Medical was founded in 2019. It employs 101 to 250 people.
Where is Nalu Medical based?
Nalu Medical is headquartered in Carlsbad, United States, in the North America region.
How does Nalu Medical make money?
One revenue line is on record: neurostimulation System Sales.
Who are Nalu Medical's main competitors?
Direct peers on record are Nevro Corp, Saluda Medical and Curonix (formerly Stimwave). Broad incumbents are Medtronic, Abbott, Boston Scientific and Biotronik. Emerging players are SPR Therapeutics and Axonics.
Does Nalu Medical have an API?
No public API is recorded for Nalu Medical.
What industry is Nalu Medical in?
Nalu Medical's product category is Implantable Neurostimulation Devices. Its primary akta.pro industry code is HLAHAEAK, Implantable Neuromodulation & Neurostimulation (SCS/DBS/VNS/PNS), with a secondary code of HLAKAIAM, Pain Medicine (Interventional/Neuropathic Pain). Its NAICS code is 339113 and its SIC code is 3845.